Worldwide Genetic Variability of the Duffy Binding Protein: Insights into Plasmodium vivax Vaccine Development

被引:30
作者
de Sousa, Tais Nobrega [1 ]
Carvalho, Luzia Helena [1 ]
Alves de Brito, Cristiana Ferreira [1 ]
机构
[1] Ctr Pesquisa Rene Rachou Fiocruz, Lab Malaria, Belo Horizonte, MG, Brazil
来源
PLOS ONE | 2011年 / 6卷 / 08期
关键词
HUMAN MALARIA PARASITE; POPULATION-STRUCTURE; LIGAND DOMAIN; INHIBITORY ANTIBODIES; NATURAL-SELECTION; BLOOD-GROUP; ANTIGEN; INFECTION; POLYMORPHISMS; TRANSMISSION;
D O I
10.1371/journal.pone.0022944
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The dependence of Plasmodium vivax on invasion mediated by Duffy binding protein (DBP) makes this protein a prime candidate for development of a vaccine. However, the development of a DBP-based vaccine might be hampered by the high variability of the protein ligand (DBPII), known to bias the immune response toward a specific DBP variant. Here, the hypothesis being investigated is that the analysis of the worldwide DBPII sequences will allow us to determine the minimum number of haplotypes (MNH) to be included in a DBP-based vaccine of broad coverage. For that, all DBPII sequences available were compiled and MNH was based on the most frequent nonsynonymous single nucleotide polymorphisms, the majority mapped on B and T cell epitopes. A preliminary analysis of DBPII genetic diversity from eight malaria-endemic countries estimated that a number between two to six DBP haplotypes (17 in total) would target at least 50% of parasite population circulating in each endemic region. Aiming to avoid region-specific haplotypes, we next analyzed the MNH that broadly cover worldwide parasite population. The results demonstrated that seven haplotypes would be required to cover around 60% of DBPII sequences available. Trying to validate these selected haplotypes per country, we found that five out of the eight countries will be covered by the MNH (67% of parasite populations, range 48-84%). In addition, to identify related subgroups of DBPII sequences we used a Bayesian clustering algorithm. The algorithm grouped all DBPII sequences in six populations that were independent of geographic origin, with ancestral populations present in different proportions in each country. In conclusion, in this first attempt to undertake a global analysis about DBPII variability, the results suggest that the development of DBP-based vaccine should consider multi-haplotype strategies; otherwise a putative P. vivax vaccine may not target some parasite populations.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Plasmodium simium, a Plasmodium vivax-Related Malaria Parasite: Genetic Variability of Duffy Binding Protein II and the Duffy Antigen/Receptor for Chemokines
    Costa, Daniela Camargos
    Pereira de Assis, Gabriela Maria
    de Souza Silva, Flavia Alessandra
    Araujo, Flavia Carolina
    de Souza Junior, Julio Cesar
    Braga Hirano, Zelinda Maria
    Kano, Flora Satiko
    de Sousa, Tais Nobrega
    Carvalho, Luzia Helena
    Alves de Brito, Cristiana Ferreira
    PLOS ONE, 2015, 10 (06):
  • [2] Plasmodium vivax Duffy Binding Protein-Based Vaccine: a Distant Dream
    Kar, Sonalika
    Sinha, Abhinav
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [3] Glycan Masking of Plasmodium vivax Duffy Binding Protein for Probing Protein Binding Function and Vaccine Development
    Sampath, Sowmya
    Carrico, Chris
    Janes, Joel
    Gurumoorthy, Sairam
    Gibson, Claire
    Melcher, Martin
    Chitnis, Chetan E.
    Wang, Ruobing
    Schief, William R.
    Smith, Joseph D.
    PLOS PATHOGENS, 2013, 9 (06)
  • [4] Genetic diversity and natural selection of Duffy binding protein of Plasmodium vivax Korean isolates
    Ju, Hye-Lim
    Kang, Jung-Mi
    Moon, Sung-Ung
    Bahk, Young-Yil
    Cho, Pyo-Yun
    Sohn, Woon-Mok
    Park, Yun-Kyu
    Park, Jae-Won
    Kim, Tong-Soo
    Na, Byoung-Kuk
    ACTA TROPICA, 2013, 125 (01) : 67 - 74
  • [5] The Duffy binding protein as a key target for a Plasmodium vivax vaccine: lessons from the Brazilian Amazon
    de Sousa, Tais Nobrega
    Kano, Flora Satiko
    Alves de Brito, Cristiana Ferreira
    Carvalho, Luzia Helena
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2014, 109 (05): : 608 - 617
  • [6] Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein
    Chen, Edwin
    Salinas, Nichole D.
    Huang, Yining
    Ntumngia, Francis
    Plasencia, Manolo D.
    Gross, Michael L.
    Adams, John H.
    Tolia, Niraj Harish
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (22) : 6277 - 6282
  • [7] Genetic variability and natural selection at the ligand domain of the Duffy binding protein in brazilian Plasmodium vivax populations
    Sousa, Tais N.
    Tarazona-Santos, Eduardo M.
    Wilson, Daniel J.
    Madureira, Ana P.
    Falcao, Paula R. K.
    Fontes, Cor J. F.
    Gil, Luiz H. S.
    Ferreira, Marcelo U.
    Carvalho, Luzia H.
    Brito, Cristiana F. A.
    MALARIA JOURNAL, 2010, 9
  • [8] Genetic polymorphism and natural selection of Duffy binding protein of Plasmodium vivax Myanmar isolates
    Ju, Hye-Lim
    Kang, Jung-Mi
    Moon, Sung-Ung
    Kim, Jung-Yeon
    Lee, Hyeong-Woo
    Lin, Khin
    Sohn, Woon-Mok
    Lee, Jin-Soo
    Kim, Tong-Soo
    Na, Byoung-Kuk
    MALARIA JOURNAL, 2012, 11
  • [9] An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies
    Ntumngia, Francis B.
    Pires, Camilla V.
    Barnes, Samantha J.
    George, Miriam T.
    Thomson-Luque, Richard
    Kano, Flora S.
    Alves, Jessica R. S.
    Urusova, Darya
    Pereira, Dhelio B.
    Tolia, Niraj H.
    King, Christopher L.
    Carvalho, Luzia H.
    Adams, John H.
    SCIENTIFIC REPORTS, 2017, 7
  • [10] Designing an effective malaria vaccine targeting Plasmodium vivax Duffy-binding protein
    Dickey, Thayne H.
    Tolia, Niraj H.
    TRENDS IN PARASITOLOGY, 2023, 39 (10) : 850 - 858